Paper39458656
Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy.
Zhang H and 5 others. Pharmaceutics, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy. Papers, record 39458656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33373606 | Dual Redox/pH-Sensitive Micelles Self-Assembled From Star-Like Amphiphilic Copolymers Based On Sucrose For Controlled Doxorubicin Delivery. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/33373606 | PubMed |
| 2 | 34678274 | Engineered Hyaluronic Acid-Based Smart Nanoconjugates for Enhanced Intracellular Drug Delivery. | J Pharm Sci | 2023 | https://conductscience.org/library/papers/34678274 | PubMed |
| 3 | 20117198 | Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector. | Int J Pharm | 2010 | https://conductscience.org/library/papers/20117198 | PubMed |
| 4 | 34256270 | Redox-sensitive irinotecan liposomes with active ultra-high loading and enhanced intracellular drug release. | Colloids Surf B Biointerfaces | 2021 | https://conductscience.org/library/papers/34256270 | PubMed |
| 5 | 27424081 | Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release. | Acta Biomater | 2016 | https://conductscience.org/library/papers/27424081 | PubMed |
| 6 | 36235055 | pH-Responsive Drug Delivery and Imaging Study of Hybrid Mesoporous Silica Nanoparticles. | Molecules | 2022 | https://conductscience.org/library/papers/36235055 | PubMed |
| 7 | 36395923 | Redox-Sensitive multifunctional hyaluronic acid-based nanomicelles with Fine-controlled anticancer drug release. | Int J Pharm | 2022 | https://conductscience.org/library/papers/36395923 | PubMed |
| 8 | 31208270 | Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecan. | MAbs | 2019 | https://conductscience.org/library/papers/31208270 | PubMed |
| 9 | 34121558 | Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34121558 | PubMed |
| 10 | 17540344 | Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity. | Biochem Pharmacol | 2007 | https://conductscience.org/library/papers/17540344 | PubMed |
| 11 | 15157882 | On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation. | Chem Biol | 2004 | https://conductscience.org/library/papers/15157882 | PubMed |
| 12 | 36711109 | Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy. | Asian J Pharm Sci | 2023 | https://conductscience.org/library/papers/36711109 | PubMed |
| 13 | 34119559 | Redox-sensitive hyaluronic acid-cholesterol nanovehicles potentiate efficient transmembrane internalization and controlled release for penetrated "full-line" inhibition of pre-metastatic initiation. | J Control Release | 2021 | https://conductscience.org/library/papers/34119559 | PubMed |
| 14 | 33463329 | Effect of Poly(ethylene glycol) (PEG) Surface Density on the Fate and Antitumor Efficacy of Redox-Sensitive Hybrid Nanoparticles. | ACS Biomater Sci Eng | 2020 | https://conductscience.org/library/papers/33463329 | PubMed |
| 15 | 25238329 | Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery. | Mol Pharm | 2014 | https://conductscience.org/library/papers/25238329 | PubMed |
| 16 | 34175539 | Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/34175539 | PubMed |
| 17 | 36077300 | Erythro-Magneto-HA-Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077300 | PubMed |
| 18 | 27796093 | CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery. | Mol Pharm | 2016 | https://conductscience.org/library/papers/27796093 | PubMed |
| 19 | 34348617 | Nanotherapeutics and Nanotheragnostics for Cancers: Properties, Pharmacokinetics, Biopharmaceutics, and Biosafety. | Curr Pharm Des | 2022 | https://conductscience.org/library/papers/34348617 | PubMed |
| 20 | 31735094 | Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy. | Drug Deliv | 2019 | https://conductscience.org/library/papers/31735094 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41594677 | Magnetic Nanocarriers with ICPTES- and GPTMS-Functionalized Quaternary Chitosan for pH-Responsive Doxorubicin Release. | Biomolecules | 2026 | https://conductscience.org/library/papers/41594677 | PubMed |
| 41528374 | Camptothecin Nanoformulations: Recent Advances in Preparation, Bioactivities, and Clinical Perspectives. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/41528374 | PubMed |
| 40362369 | Preparation and Characterization of a Glutathione-Responsive Doxorubicin Prodrug Modified by 2-Nitrobenzenesulfonamide Group-Its Selective Cytotoxicity Toward Cells with Enhanced Glutathione Production. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362369 | PubMed |
| 40325469 | Improving epilepsy management by targeting P2 × 7 receptor with ROS/electric responsive nanomicelles. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40325469 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458656
GET https://conductscience.org/api/papers/v1/39458656/references?page=2